We mined Medtronic's acquisitions, investments, and partnerships to understand the company's strategic priorities.
Medtronic has been a leader in healthcare tech innovation for decades. It created the first implantable pacemaker, for example, and later introduced a prosthetic heart valve.
The company is now the largest medical device manufacturer in the world by total revenue, ahead of Johnson & Johnson MedTech and Siemens Healthineers — and it’s still innovating.
Medtronic has invested in more than 35 medical device companies over the last 5 years to expand the range of its specializations and add cutting-edge tech solutions to its portfolio. These solutions include neurostimulation devices to address movement disorders, remote monitoring systems to continuously track a patient’s health status, and robotics for surgical assistance.
Using CB Insights data, we uncovered 5 important strategic priorities highlighted by Medtronic’s recent acquisitions, investments, and partnerships. We then categorized companies by their business relationships with Medtronic across these priorities:
- Artificial intelligence
- Drug delivery systems
- Remote monitoring
- Robotics
- Surgical intelligence
